The 2-Minute Rule for AM 2201 UK
This study proposes that K2's large adverse result incidence is due, at the least partially, to distinctive JWH-018 metabolite activity on the cannabinoid 1 receptor (CB1R), and suggests that metabolites of most medicines, although not the carboxy metabolite, keep in vitro As well as in vivo action at CB1Rs.In vitro and in vivo metabolism of AM-220